MapLight Therapeutics, Inc. MPLT Ratios & Valuation
| FY'25 | ||
|---|---|---|
| Returns | ||
| Return on assets | -52.3%— | |
| Liquidity | ||
| Current ratio | 20×+12.8× | |
| Quick ratio | 20×+12.8× | |
| Cash ratio | 2.9×+0.5× | |
| Leverage | ||
| Debt-to-equity | 0×— | |
| Debt-to-assets | 0×0.0× | |
| Per Share | ||
| Book value per share | $52.80+120% | |
| Valuation | ||
| Market capitalization | $1.39B+100% | |
| Enterprise value | $1.34B— | |
| Price / book | 3.5×— | |
| Earnings yield | -14.4%— |
Questions, answered.
- Where do MapLight Therapeutics, Inc. 's ratios come from?
- Every ratio is computed from MapLight Therapeutics, Inc. 's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.